LSM values (kPa) | Sex | Age (years) | BMI (kg/m2) | GGT (ULN) | ALT (ULN) | Platelet count (109/l) | Causes of liver disease | Fibrosis score* | Activity score | Steatosis (%) |
8 ≤LSM >13 (n=18) | ||||||||||
8 | M | 73 | 31 | 1.2 | 1 | 248 | NAFLD | F1 | A0 | <10 |
8.1 | M | 60 | 27 | 3.5 | 1 | 276 | ALD | F1 | A0 | <10 |
8.2 | F | 58 | 29 | 1.1 | 1.2 | 204 | PBC | F2 | A1 | 10–30 |
8.6 | M | 57 | 27 | 1.1 | 1 | 364 | NAFLD | F1 | A0 | 10–30 |
8.6 | M | 48 | 28 | 1.2 | 1.3 | 155 | NAFLD | F1 | A1 | 10–30 |
8.6 | M | 56 | 18 | 1 | 1 | 268 | ALD | F1 | A1 | 0 |
8.9 | M | 53 | 28 | 1.1 | 1.2 | 230 | NAFLD | F2 | A1 | 30–60 |
10.0 | M | 74 | 30 | 1 | 1 | 344 | ALD | F2 | A2 | 10–30 |
10.2 | M | 50 | 44 | 1.5 | 1.25 | 283 | NAFLD | F0 | A0 | 10–30 |
10.3 | M | 70 | 28 | 1 | 1 | 219 | NAFLD | F2 | A2 | 10–30 |
10.3 | M | 50 | 34 | 1 | 3 | 241 | NAFLD | F1 | A1 | >60 |
10.6 | M | 55 | 29 | 4.2 | 1.7 | 171 | ALD | F1 | A1 | 30–60 |
10.6 | M | 44 | 26 | 1 | 1 | 156 | HBV | F1 | A1 | <10 |
10.7 | M | 64 | 35 | 1 | 1 | 198 | HBV | F2 | A1 | 30–60 |
10.7 | M | 66 | 30 | 2.6 | 2.2 | 299 | HCV | F2 | A2 | 10–30 |
10.7 | M | 52 | 20 | 13 | 2 | 174 | ALD | F2 | A1 | >60 |
10.9 | M | 66 | 20 | 1.2 | 1 | 177 | ALD | F2 | A0 | 30–60 |
11.8 | M | 71 | 34 | 1.5 | 2 | 272 | NAFLD | F2 | A1 | >60 |
LSM ≥13 (n=9) | ||||||||||
13.7 | M | 78 | 27 | 1 | 1 | 188 | HCV | F4 | A1 | 0 |
15.5 | M | 69 | 23 | 1.1 | 1 | 348 | ALD | F4 | A1 | 10–30 |
16.3 | M | 74 | 23 | 5.4 | 1 | 143 | ALD | F4 | A1 | <10 |
17.6 | M | 74 | 29 | 5.4 | 3.8 | 170 | HCV | F4 | A2 | 10–30 |
20.7 | F | 71 | 31 | 6.7 | 3 | 237 | ALD | F4 | A2 | 10–30 |
21.3 | M | 58 | 32 | 4 | 5.4 | 176 | HCV | F4 | A3 | 10–30 |
24.8 | M | 65 | 24 | 4 | 4.4 | 151 | HBV | F4 | A1 | <10 |
25.7 | M | 71 | 27 | 1.6 | 1.1 | 50 | ALD | F4 | A1 | <30 |
35.0 | M | 61 | 21 | 26.5 | 1.1 | 104 | ALD | F4 | A1 | 10–30 |
Data on 27 individuals undergoing liver biopsy out of 89 subjects with LSM ≥8 kPa.
↵* According to the Metavir score in the case of viral hepatitis and to the Brunt score in the case of NAFLD or ALD.
ALD, alcoholic liver disease; ALT, alanine aminotransferase; BMI, body mass index; GGT, γ-glutamyltranspeptidase; HBV, hepatitis B virus; HCV, hepatitis C virus; LSM, liver stiffness measurement; NAFLD, non-alcoholic fatty liver disease; PBC, primary biliary cirrhosis; ULN, upper limit of normal values.